The purpose of the study is to find out more about a protien, AMG 181, in people with moderate to severe Crohn’s disease. This study will evaluate whether the protein prevents immune cells from migrating into the gut and worsening the inflammation there. Register Today!
Ulcerative Colitis (APD334-005)
The purpose of this extension study is to find out more about the safety and efficacy of APD334 for the treatment of moderately to severely active ulcerative colitis. APD334 is an experimental drug which has not yet been approved by Health Authorities in any country of the world for the treatment of moderately or severely…
Boostrix Vaccine 6 month (201334)
The purpose of this study is to assess the immunogenicity and safety of the Infanrix hexa booster dose given at 12-18 months of age to infants who received primary vaccination at 6-12 weeks. All infants in this booster study were born to pregnant women who participated in the study 116945 [DTPA (BOOSTRIX)-047]. Register Today!
Boostrix Vaccine 2 Month (201330)
The purpose of this study is to evaluate the immunogenicity and safety of GSK Biologicals’ Infanrix hexa, given in the primary vaccination schedule to infants born to pregnant women who participated in study 116945 [DTPA (BOOSTRIX)-047]. This study will help us evaluate if the presence of transplacentally transferred maternal antibodies interfere with the immune response…
COPD (PT009002 “Pearl”)
People with COPD usually have one or more of these symptoms: a cough that lasts a long time (longer than 3 months) a cough with mucus feeling short of breath lung infections (the flu, acute bronchitis, pneumonia, etc) that may last longer than other people you know wheezing (a whistling sound when you breathe) feeling…
Overactive Bladder (178-MA-1005)
Overactive Bladder (OAB) is a frequent condition affecting older adults and the urinary frequency and urgency associated with the condition are often highly debilitating. In addition, OAB related urinary incontinence has been associated with other health related problems in seniors including falls, fractures, urinary tract infections (UTIs), skin infections, depression, and chronic constipation. The purpose…
Uterine Fibroids (M12-817)
The purpose of this study is to determine the safety of elagolix and how elagolix works when compared to placebo in reducing heavy menstrual bleeding, the major symptom of uterine fibroids. Register Today!
Boostrix Vaccine (Pregnant Women)
GSK Biologicals’ reduced-antigen-content dTpa vaccine, Boostrix, is a combination booster vaccine (a vaccine against more than one disease combined into one shot) indicated for individuals from the age of four years onwards against diphtheria, tetanus and pertussis diseases. It was first licensed for use in Germany in 1999. A number of studies have shown that…
Type II Diabetes with High Vascular Risk (1218.22 “Carmelina”)
The purpose of the CARMELINA Study is to look at the impact of an investigational drug called linagliptin on the long-term occurrence of selected complications of cardiovascular disease (e.g. stroke or heart attack), as compared to placebo, in people with type 2 diabetes mellitus receiving standard of care. Register Today!
Diabetes (DIA-3008 “Canvas”)
Over the past decades, the incidence of type 2 diabetes mellitus (T2DM) has been rapidly rising worldwide, driven primarily by an increasing incidence of obesity and sedentary lifestyles. Patients with T2DM can develop severe microvascular complications, related to persistently elevated glucose concentrations, including blindness, renal failure, or nerve damage, and have a higher incidence of…